| Scientific Presentations | ||||
|---|---|---|---|---|
| VEGF Trap-Eye Phase 2 DME Primary Analysis | Feb 20, 2010 |
|
315.9 KB | |
| VEGF Trap-Eye in Wet AMD: Update on Phase 2 Studies. | Oct 25, 2009 |
|
932.7 KB | |
| VEGF Trap-Eye in Wet AMD CLEAR-IT 2: Summary of One-Year Key Results | Sep 28, 2008 |
|
393.4 KB | |
| Rilonacept Phase II Gout Data | Sep 3, 2008 |
|
12.6 MB | |
| Financial Presentations | ||||
|---|---|---|---|---|
| Cowen and Company 30th Annual Healthcare Conference | Mar 9, 2010 |
|
1.0 MB | |
| 28th Annual J.P. Morgan Healthcare Conference Presentation | Jan 13, 2010 |
|
2.4 MB | |
| Credit Suisse Annual Healthcare Conference Presentation | Nov 11, 2009 |
|
1.1 MB | |
| Conference Call to Discuss Expanded Antibody Collaboration with Sanofi-aventis | Nov 11, 2009 |
|
222.4 KB | |
Stock Information
| NASDAQ:REGN
$25.50 - 0.28 |
Mar 11, 2010
4:00 PM ET |
Quotes delay at least 20min., by eSignal.
